Japanese Ministry Recommends Approval For J&J, GSK Drugs; Takeda Actos/Alogliptin Combo Missing
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare has recommended 10 drugs for marketing approval; these include new drugs from Johnson & Johnson, Eli Lilly, GlaxoSmithKline and Nippon Medi-Physics